Abeona Therapeutics Inc. (ABEO)
NASDAQ
Market Cap
$167.54M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
188 of 809
Rank in Industry
118 of 445
Largest Insider Buys in Sector
ABEO Stock Price History Chart
ABEO Stock Performance
About Abeona Therapeutics Inc.
Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead program is EB-101, an autologous, gene-corrected cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa. The company also develops ABO-102, an adeno-associated virus (AAV)-based gene therapy for Sanfilippo syndrome type A; ABO-201 to treat CLN3 disease; ABO-401 for the treatment of cystic fibrosis; and ABO-50X for the treatment of genetic eye disorders. In addition, it is developing AAV-based gene therapy through its AIM vector platform programs. The company was formerly known as PlasmaTech Biopharmaceuticals, Inc. and changed its name to Abeona Therapeutics Inc. in June 2015. Abeona Therapeutics Inc. was incorporated in 1974 and is headquartered in New York, New York.
Insider Activity of Abeona Therapeutics Inc.
Over the last 12 months, insiders at Abeona Therapeutics Inc. have bought $346,094 and sold $410,872 worth of Abeona Therapeutics Inc. stock.
On average, over the past 5 years, insiders at Abeona Therapeutics Inc. have bought $301,463 and sold $1.07M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Seshadri Vishwas (Chief Executive Officer) — $201,200. Alland Leila (director) — $103,598. Vazzano Joseph Walter (Chief Financial Officer) — $58,135.
The last purchase of 11,000 shares for transaction amount of $51,799 was made by Alland Leila (director) on 2024‑05‑16.
List of Insider Buy and Sell Transactions, Abeona Therapeutics Inc.
| 2024-06-18 | Sale | Silverstein Christine Berni | director | 25,821 0.0635% | $4.51 | $116,453 | -2.31% | |
| 2024-06-18 | Sale | Alvino Mark | director | 25,890 0.0637% | $4.51 | $116,764 | -2.31% | |
| 2024-05-16 | Alland Leila | director | 11,000 0.0286% | $4.71 | $51,799 | -4.65% | ||
| 2024-04-26 | Charles Faith L. | director | 7,550 0.0265% | $3.28 | $24,764 | +34.97% | ||
| 2024-04-25 | Seshadri Vishwas | Chief Executive Officer | 10,000 0.0343% | $3.20 | $32,000 | +37.30% | ||
| 2024-04-25 | Vazzano Joseph Walter | Chief Financial Officer | 5,608 0.0189% | $3.14 | $17,609 | +37.30% | ||
| 2024-04-25 | O'Malley Brendan M. | SVP, General Counsel | 8,600 0.0299% | $3.24 | $27,864 | +37.30% | ||
| 2024-02-06 | Seshadri Vishwas | Chief Executive Officer | 20,000 0.0784% | $4.39 | $87,800 | +45.47% | ||
| 2024-01-17 | Sale | Alvino Mark | director | 7,084 0.0285% | $5.11 | $36,199 | -4.88% | |
| 2023-09-27 | Sale | Amoroso Michael | director | 5,508 0.022% | $3.91 | $21,542 | +18.06% | |
| 2023-09-27 | Sale | Silverstein Christine Berni | director | 6,330 0.0252% | $3.91 | $24,721 | +18.06% | |
| 2023-09-27 | Sale | Alland Leila | director | 7,246 0.0288% | $3.90 | $28,270 | +18.06% | |
| 2023-09-27 | Sale | Charles Faith L. | director | 8,330 0.0417% | $4.91 | $40,924 | +18.06% | |
| 2023-09-27 | Sale | Alvino Mark | director | 6,316 0.0252% | $3.91 | $24,724 | +18.06% | |
| 2023-09-27 | Seshadri Vishwas | Chief Executive Officer | 20,000 0.083% | $4.07 | $81,400 | +18.06% | ||
| 2023-09-20 | Sale | Amoroso Michael | director | 327 0.0014% | $3.90 | $1,275 | +21.32% | |
| 2023-09-19 | Vazzano Joseph Walter | Chief Financial Officer | 3,000 0.0122% | $3.82 | $11,458 | +21.37% | ||
| 2023-09-18 | O'Malley Brendan M. | SVP, General Counsel | 3,000 0.0125% | $3.80 | $11,400 | +25.07% | ||
| 2023-06-20 | Sale | Amoroso Michael | director | 338 0.0039% | $4.45 | $1,504 | -3.52% | |
| 2023-04-25 | Sale | Alvino Mark | director | 887 0.0105% | $3.25 | $2,883 | +31.60% |
Insider Historical Profitability
<0.0001%
| Seshadri Vishwas | Chief Executive Officer | 538260 2.1324% | $4.09 | 3 | 0 | |
| Vazzano Joseph Walter | Chief Financial Officer | 233868 0.9614% | $4.09 | 3 | 0 | <0.0001% |
| O'Malley Brendan M. | SVP, General Counsel | 188718 0.7565% | $4.09 | 4 | 5 | <0.0001% |
| Amoroso Michael | director | 108957 0.4398% | $4.09 | 0 | 7 | |
| Silverstein Christine Berni | director | 62063 0.3548% | $4.09 | 0 | 2 | |
| Alland Leila | director | 82857 0.2901% | $4.09 | 1 | 1 | |
| Charles Faith L. | director | 78323 0.2857% | $4.09 | 1 | 1 | |
| Alvino Mark | director | 36926 0.2536% | $4.09 | 0 | 6 | |
| SCO CAPITAL PARTNERS LLC | 11079292 44.7227% | $4.09 | 0 | 11 | ||
| Ayer Capital Management, LP | 10 percent owner | 2413163 9.741% | $4.09 | 0 | 4 | |
| CARR EDWARD | Chief Financial Officer | 400169 1.6153% | $4.09 | 0 | 4 | |
| Ahn Mark J | director | 343182 1.3853% | $4.09 | 2 | 0 | <0.0001% |
| Rouhandeh Steven H | 315042 1.2717% | $4.09 | 1 | 0 | +20.49% | |
| FEINBERG LARRY N | 10 percent owner | 296483 1.1968% | $4.09 | 5 | 11 | |
| Buono Stefano | director | 270000 1.0899% | $4.09 | 3 | 0 | <0.0001% |
| GRAY KERRY P | President and CEO | 183340 0.7401% | $4.09 | 2 | 0 | |
| MCDADE HERBERT H | director | 81007 0.327% | $4.09 | 0 | 1 | |
| Howell Stephen B. | director | 79494 0.3209% | $4.09 | 1 | 0 | <0.0001% |
| Jeffrey B Davis | director | 67858 0.2739% | $4.09 | 1 | 0 | +20.49% |
| NOWOTNIK DAVID P | Sr Vice President R&D | 62000 0.2503% | $4.09 | 1 | 0 | |
| Meakem John J | director | 45000 0.1816% | $4.09 | 3 | 0 | |
| Van Duyne Richard B | director | 6000 0.0242% | $4.09 | 1 | 0 | <0.0001% |
| Wider Todd | director | 0 0% | $4.09 | 2 | 8 | <0.0001% |
| Mann Paul Elliot | director | 0 0% | $4.09 | 0 | 6 |
Institutional Investor Ownership
Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
| Adage Capital Partners Gp L L C | $23.56M | 7.89 | 3.25M | 0% | +$0 | 0.04 | |
| Nantahala Capital Management Llc | $16.75M | 5.61 | 2.31M | +2.68% | +$437,813.00 | 1.72 | |
| Millennium Management LLC | $14.4M | 4.82 | 1.99M | +40.03% | +$4.12M | 0.01 | |
| Western Standard Llc | $9.87M | 3.31 | 1.36M | +68.48% | +$4.01M | 13.34 | |
| The Vanguard Group | $7.99M | 2.68 | 1.1M | +0.07% | +$5,995.75 | <0.0001 | |
| Ikarian Capital LLC | $6.44M | 2.16 | 888,593 | +48.1% | +$2.09M | 1.84 | |
| Laurion Capital Management LP | $4.69M | 1.57 | 646,830 | New | +$4.69M | 0.13 | |
| Citigroup | $3.51M | 1.18 | 484,054 | +7.49% | +$244,375.79 | <0.01 | |
| Boothbay Fund Management LLC | $1.96M | 0.66 | 270,340 | +68.69% | +$798,080.00 | 0.07 | |
| Walleye Capital | $1.93M | 0.65 | 266,114 | +41.54% | +$566,210.65 | 0.01 | |
| Geode Capital Management | $1.75M | 0.59 | 241,791 | +10.21% | +$162,483.46 | <0.0001 | |
| BlackRock | $1.6M | 0.54 | 220,549 | +18.34% | +$247,768.87 | <0.0001 | |
| Goldman Sachs | $1.24M | 0.42 | 171,533 | New | +$1.24M | <0.0001 | |
| Marshall Wace | $934,548.00 | 0.31 | 128,903 | +169.36% | +$587,591.54 | <0.01 | |
| Northern Trust | $933,082.00 | 0.31 | 128,701 | -2.44% | -$23,359.49 | <0.0001 | |
| BNY Mellon | $862,885.00 | 0.29 | 119,019 | +793.54% | +$766,315.31 | <0.0001 | |
| State Street | $623,464.00 | 0.21 | 85,995 | +11.69% | +$65,250.03 | <0.0001 | |
| Renaissance Technologies | $535,000.00 | 0.18 | 73,837 | -59.52% | -$786,563.10 | <0.01 | |
| Man Group Plc | $535,224.00 | 0.18 | 73,824 | New | +$535,224.00 | <0.01 | |
| Qube Research & Technologies | $527,786.00 | 0.18 | 72,798 | +3,978.32% | +$514,844.74 | <0.01 | |
| Hrt Financial Llc | $500,000.00 | 0.17 | 69,051 | New | +$500,000.00 | <0.01 | |
| Jane Street Capital | $467,705.00 | 0.16 | 64,511 | +57.78% | +$171,274.09 | <0.01 | |
| Barclays | $409,000.00 | 0.14 | 56,394 | -66.78% | -$821,988.90 | <0.0001 | |
| Morgan Stanley | $225,005.00 | 0.08 | 31,035 | +96.04% | +$110,229.61 | <0.0001 | |
| LINSCO PRIVATE LEDGER CORP | $221,415.00 | 0.07 | 30,540 | +4.09% | +$8,700.00 | <0.0001 | |
| Susquehanna International Group | $199,129.00 | 0.07 | 27,466 | -33.27% | -$99,281.75 | <0.0001 | |
| Jump Financial Llc | $184,440.00 | 0.06 | 25,440 | -36.01% | -$103,798.25 | <0.01 | |
| Gsa Capital Partners Llp | $178,000.00 | 0.06 | 24,561 | New | +$178,000.00 | 0.01 | |
| Bank of America | $166,816.00 | 0.06 | 23,009 | -54.95% | -$203,464.92 | <0.0001 | |
| J. Goldman & Company | $164,938.00 | 0.06 | 22,750 | -94.71% | -$2.95M | 0.01 | |
| JPMorgan Chase | $157,065.00 | 0.05 | 21,664 | +154,642.86% | +$156,963.50 | <0.0001 | |
| Balyasny Asset Management Llc | $137,939.00 | 0.05 | 19,026 | New | +$137,939.00 | <0.0001 | |
| Engineers Gate Manager Lp | $128,760.00 | 0.04 | 17,760 | New | +$128,760.00 | <0.01 | |
| Tower Research Capital | $117,015.00 | 0.04 | 16,140 | +701.39% | +$102,413.50 | <0.01 | |
| Creative Planning | $108,786.00 | 0.04 | 15,005 | New | +$108,786.00 | <0.0001 | |
| Squarepoint Ops LLC | $105,270.00 | 0.04 | 14,520 | +45.2% | +$32,770.00 | <0.0001 | |
| Palumbo Wealth Management | $104,168.00 | 0.04 | 14,368 | New | +$104,168.00 | 0.05 | |
| Ci Private Wealth Llc | $100,790.00 | 0.03 | 13,902 | 0% | +$0 | <0.0001 | |
| Y Intercept Hong Kong Ltd | $101,667.00 | 0.03 | 14,023 | +34.66% | +$26,165.31 | 0.01 | |
| Acadian Asset Management | $91,000.00 | 0.03 | 12,634 | New | +$91,000.00 | <0.0001 | |
| OMERS | $89,900.00 | 0.03 | 12,400 | New | +$89,900.00 | <0.01 | |
| UBS | $75,814.00 | 0.03 | 10,457 | New | +$75,814.00 | <0.0001 | |
| Simplex Trading Llc | $15,000.00 | 0.01 | 2,154 | -54.82% | -$18,203.34 | <0.0001 | |
| Group One Trading | $12,738.00 | <0.01 | 1,757 | +129.37% | +$7,184.61 | <0.0001 | |
| Advisor Group Holdings Inc | $8,011.00 | <0.01 | 1,105 | -57.58% | -$10,874.66 | <0.0001 | |
| LAZARD ASSET MANAGEMENT LLC | $7,000.00 | <0.01 | 1,124 | New | +$7,000.00 | <0.0001 | |
| Hartford Financial Management Inc | $5,220.00 | <0.01 | 720 | 0% | +$0 | <0.01 | |
| Royal Bank of Canada | $6,000.00 | <0.01 | 800 | -20.71% | -$1,567.50 | <0.0001 | |
| Macquarie Group | $6,000.00 | <0.01 | 760 | New | +$6,000.00 | <0.0001 | |
| Parallel Advisors, LLC | $2,900.00 | <0.01 | 400 | 0% | +$0 | <0.0001 |